News about Market

HRV Pharma Invests INR 150 Crore to Expand Peptide and High-Potent API Capabilities

HRV Pharma invests INR 150 crore to expand peptide and high-potent Active Pharmaceutical Ingredient (API) capabilities, strengthening its position in high-value pharmaceutical segments.

Market | 08/09/2026 | By News Bureau |  130

Aptar and Aceso Therapeutics Partner on Inhaled Antisense Therapy for Cystic Fibrosis

Aptar and Aceso Therapeutics collaborate to advance inhaled antisense therapy ACT-101 for cystic fibrosis through formulation development and device assessment.

Market | 08/09/2026 | By News Bureau

Biocon Secures 10-Year Supply Contract for Pertuzumab in Brazil

Biocon secures a 10-year Pertuzumab supply contract in Brazil after its consortium with Bahiafarma and Bionovis receives 100% allocation under the PDP program.

Market | 08/09/2026 | By News Bureau

Cipla and Qilu Pharmaceutical Partner on Keytruda Biosimilar for US

Cipla partners with Qilu Pharmaceutical to license and supply a Keytruda (pembrolizumab) biosimilar in the US, aiming to expand access to cancer therapies.

Market | 07/09/2026 | By News Bureau

IP Alliance to Host 11th Advanced GMP Workshop on Quality Systems for the Next Decade

IP Alliance’s 11th Advanced GMP Workshop will focus on strengthening pharmaceutical quality systems amid evolving technology, manufacturing practices and regulatory requirements.

Market | 07/09/2026 | By News Bureau |  130

Evinova and Lothar Medical Launch Unified Solution for Respiratory Trials

Evinova and Lothar Medical partner to modernise respiratory clinical trials by integrating connected devices with Evinova’s Unified Trial Solution.

Market | 07/09/2026 | By News Bureau

DKMS Marks 1,000 Paediatric Stem Cell Transplants in India Amid Thalassemia Donor Shortage

DKMS Foundation India and Sankalp India Foundation mark 1,000 paediatric stem cell transplants, spotlighting India’s donor shortage and the need to expand access to potentially curative thalassemia treatment.

Market | 05/09/2026 | By News Bureau

AbbVie Completes Acquisition of Apogee Therapeutics

AbbVie completes its acquisition of Apogee Therapeutics, strengthening its immunology pipeline with assets targeting dermatologic, respiratory and inflammatory diseases.

Market | 05/09/2026 | By News Bureau

Cipla Partners with Qilu to Bring Pembrolizumab Biosimilar to US Market

Cipla and Qilu Pharmaceutical partner to commercialise QL2107, a pembrolizumab biosimilar, in the US, strengthening Cipla’s oncology and biosimilars portfolio.

Market | 04/09/2026 | By News Bureau |  100

Biocytogen Signs Non-Exclusive VHH Antibody Licensing Deal with Qilu Pharmaceutical

Biocytogen grants Qilu Pharmaceutical non-exclusive rights to a fully human VHH antibody molecule developed through its RenNano platform to support neuroscience drug research.

Market | 04/09/2026 | By News Bureau |  122